Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
Lu Zong, Hui Peng, Cheng Sun, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
Daniel Wai‐Hung Ho, Yu‐Man Tsui, Lo‐Kong Chan, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 220
HBV-Induced Immune Imbalance in the Development of HCC
Yongyan Chen, Zhigang Tian
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 212
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Yu Jiang, Qiuju Han, Huajun Zhao, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 435-450
Open Access | Times Cited: 168
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
Jiajie Hou, Haiyan Zhang, Beicheng Sun, et al.
Journal of Hepatology (2019) Vol. 72, Iss. 1, pp. 167-182
Open Access | Times Cited: 154
Hepatocellular Carcinoma Cells Up-regulate PVRL1, Stabilizing PVR and Inhibiting the Cytotoxic T-Cell Response via TIGIT to Mediate Tumor Resistance to PD1 Inhibitors in Mice
David Kung‐Chun Chiu, Vincent Wai‐Hin Yuen, Jacinth Wing‐Sum Cheu, et al.
Gastroenterology (2020) Vol. 159, Iss. 2, pp. 609-623
Open Access | Times Cited: 134
Restoring, releasing or replacing adaptive immunity in chronic hepatitis B
Mala K. Maini, Alice R. Burton
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 11, pp. 662-675
Open Access | Times Cited: 111
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Yu Jiang, Qiuju Han, Jian Zhang
World Journal of Gastroenterology (2019) Vol. 25, Iss. 25, pp. 3151-3167
Open Access | Times Cited: 103
Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
Arshi Khanam, Joel V. Chua, Shyam Kottilil
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5497-5497
Open Access | Times Cited: 91
Degrading permafrost and its impacts
Huijun Jin, Qingbai Wu, V. E. Romanovsky
Advances in Climate Change Research (2021) Vol. 12, Iss. 1, pp. 1-5
Open Access | Times Cited: 71
A TNFR2–hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells
Yan Meng, Qiudong Zhao, Liwei An, et al.
Cancer Research (2021) Vol. 81, Iss. 11, pp. 3036-3050
Open Access | Times Cited: 66
Immune Checkpoints and the Immunology of Liver Fibrosis
Ioannis Tsomidis, Argyro Voumvouraki, Elias Kouroumalis
Livers (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 1
Animal Models of Hepatocellular Carcinoma: The Role of Immune System and Tumor Microenvironment
Zuzana Macek Jílková, Keerthi Kurma, Thomas Decaens
Cancers (2019) Vol. 11, Iss. 10, pp. 1487-1487
Open Access | Times Cited: 60
TIGIT limits immune pathology during viral infections
Michelle Schorer, Nikolas Rakebrandt, Katharina Lambert, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 59
Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma
Marco Y. W. Zaki, Ahmed M. Fathi, Samara Samir, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1255-1255
Open Access | Times Cited: 36
NAFLD and HBV interplay - related mechanisms underlying liver disease progression
Evanthia Tourkochristou, Stelios F. Assimakopoulos, Konstantinos Thomopoulos, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 31
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon
Linda Galasso, Lucia Cerrito, Valeria Maccauro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7191-7191
Open Access | Times Cited: 6
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
Carolina Boni, Valeria Barili, Greta Acerbi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2754-2754
Open Access | Times Cited: 49
Immune Checkpoints in Viral Infections
Huiming Cai, Ge Liu, Jianfeng Zhong, et al.
Viruses (2020) Vol. 12, Iss. 9, pp. 1051-1051
Open Access | Times Cited: 48
Adoptive T-cell therapy for HBV-associated HCC and HBV infection
Anthony T. Tan, Sophia Schreiber
Antiviral Research (2020) Vol. 176, pp. 104748-104748
Closed Access | Times Cited: 44
Immune Checkpoint Inhibitors in HBV-Caused Hepatocellular Carcinoma Therapy
Jin Zhang, Changwei Hu, Xiaoxiao Xie, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 614-614
Open Access | Times Cited: 16
TIGIT: An emerging immune checkpoint target for immunotherapy in autoimmune disease and cancer
Junpeng Zhao, Liming Li, Huiqi Yin, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110358-110358
Closed Access | Times Cited: 13
Prognostic role of immune cells in hepatocellular carcinoma.
Meenakshi Sachdeva, Sunil Arora
PubMed (2020) Vol. 19, pp. 718-733
Closed Access | Times Cited: 35
Immune checkpoint targeting TIGIT in hepatocellular carcinoma.
Qiuxian Zheng, Jia Xu, Xinyu Gu, et al.
PubMed (2020) Vol. 12, Iss. 7, pp. 3212-3224
Closed Access | Times Cited: 33
Role of Immune Cells in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma
Hyo Jung Cho, Jae Youn Cheong
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8011-8011
Open Access | Times Cited: 31
Stat3 activation-triggered transcriptional networks govern the early stage of HBV-induced hepatic inflammation
Jinglin Tang, Jiaxuan Zhang, Gaoli Zhang, et al.
mBio (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top